Olivier Bouché

Multiplex Picodroplet Digital PCR to Detect KRAS Mutations in Circulating DNA from the Plasma of Colorectal Cancer Patients

Valérie Taly, Deniz Pekin, Léonor Benhaïm et al. · Clinical Chemistry · 2013 · 491 citations · Full text

Sorafenib and irinotecan (NEXIRI) as second- or later-line treatment for patients with metastatic colorectal cancer and KRAS-mutated tumours: a multicentre Phase I/II trial

Emmanuelle Samalin, Olivier Bouché, Simon Thézenas et al. · British Journal of Cancer · 2014 · 55 citations · Full text

Risk factors and long-term course of thyroid dysfunction during antiviral treatments in 221 patients with chronic hepatitis C

Xavier Moncoucy, F. Leymarie, Brigitte Delemer et al. · Gastroentérologie Clinique et Biologique · 2005 · 41 citations

Hepatology, Hepatitis C, Thyroid Dysfunction +8

Phase III randomized trial comparing 5-fluorouracil and oxaliplatin with or without docetaxel in first-line advanced gastric cancer chemotherapy (GASTFOX study)

Aziz Zaanan, Emmanuelle Samalin, Thomas Aparicio et al. · Digestive and Liver Disease · 2018 · 22 citations

Gastrointestinal Oncology, Medicine, Cancer Management +10

Sorafenib Plus Irinotecan Combination in Patients With RAS-mutated Metastatic Colorectal Cancer Refractory To Standard Combined Chemotherapies: A Multicenter, Randomized Phase 2 Trial (NEXIRI-2/PRODIGE 27)

Emmanuelle Samalin, Christelle de la Fouchardière, Simon Thézenas et al. · Clinical Colorectal Cancer · 2020 · 22 citations · Full text

Irinotecan Combination, Oncology, Randomized Phase 2 +9